Savara Future Growth

Future criteria checks 2/6

Savara is forecast to grow earnings and revenue by 52.3% and 71.6% per annum respectively while EPS is expected to grow by 49% per annum.

Key information

52.3%

Earnings growth rate

49.0%

EPS growth rate

Biotechs earnings growth27.6%
Revenue growth rate71.6%
Future return on equityn/a
Analyst coverage

Good

Last updated20 Dec 2024

Recent future growth updates

Recent updates

Savara: Rolling BLA Submission Of MOLBREEVI Generates Catalysts To  Track

Dec 20

Savara: Trial Successful, But I'm Only Half Convinced

Sep 09

Savara: Today's Data 'Win' Rouses Market All Too Briefly

Jun 26

Savara: The Binary Bet On Phase 3 Data

Jun 07

Health Check: How Prudently Does Savara (NASDAQ:SVRA) Use Debt?

Dec 14
Health Check: How Prudently Does Savara (NASDAQ:SVRA) Use Debt?

Is Savara (NASDAQ:SVRA) Using Too Much Debt?

Feb 16
Is Savara (NASDAQ:SVRA) Using Too Much Debt?

Is Savara (NASDAQ:SVRA) Using Too Much Debt?

Oct 12
Is Savara (NASDAQ:SVRA) Using Too Much Debt?

Savara's rare lung disorder drug gets promising innovative medicine status in UK

Aug 26

Savara GAAP EPS of -$0.06 in-line

Aug 11

Does Savara (NASDAQ:SVRA) Have A Healthy Balance Sheet?

Jan 24
Does Savara (NASDAQ:SVRA) Have A Healthy Balance Sheet?

Is Savara (NASDAQ:SVRA) A Risky Investment?

Jul 05
Is Savara (NASDAQ:SVRA) A Risky Investment?

Savara: They Failed Once, But They Are Trying Again

Jun 07

The Independent Director of Savara Inc. (NASDAQ:SVRA), David Ramsay, Just Bought 565% More Shares

Mar 17
The Independent Director of Savara Inc. (NASDAQ:SVRA), David Ramsay, Just Bought 565% More Shares

Trade Alert: The Chairman & CEO Of Savara Inc. (NASDAQ:SVRA), Matthew Pauls, Has Just Spent US$50k Buying 4,415% More Shares

Feb 26
Trade Alert: The Chairman & CEO Of Savara Inc. (NASDAQ:SVRA), Matthew Pauls, Has Just Spent US$50k Buying 4,415% More Shares

Savara's IMPALA 2 Trial Seems Well-Tailored To Get Positive Phase 3 Data For Molgradex

Nov 24

Savara EPS misses by $0.01

Nov 05

Earnings and Revenue Growth Forecasts

NasdaqGS:SVRA - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202648-45-111N/A6
12/31/20251-101-118N/A7
12/31/2024N/A-91-84N/A8
9/30/2024N/A-83-81-81N/A
6/30/2024N/A-75-72-72N/A
3/31/2024N/A-64-60-60N/A
12/31/2023N/A-55-51-51N/A
9/30/2023N/A-49-44-44N/A
6/30/2023N/A-43-39-39N/A
3/31/2023N/A-40-38-38N/A
12/31/2022N/A-38-35-35N/A
9/30/2022N/A-39-35-35N/A
6/30/2022N/A-39-36-36N/A
3/31/2022N/A-41-39-39N/A
12/31/2021N/A-43-40-40N/A
9/30/20210-45-43-43N/A
6/30/20210-46-41-41N/A
3/31/20210-44-36-36N/A
12/31/20200-50-43-40N/A
9/30/20200-68-41-37N/A
6/30/2020N/A-69-45-42N/A
3/31/2020N/A-81-51-47N/A
12/31/2019N/A-78-45-45N/A
9/30/2019N/A-57-46-46N/A
6/30/2019N/A-57-43-43N/A
3/31/2019N/A-47-41-40N/A
12/31/2018N/A-62-39-39N/A
9/30/2018N/A-58-39-38N/A
6/30/2018N/A-52N/A-38N/A
3/31/2018N/A-53N/A-35N/A
12/31/2017N/A-31N/A-28N/A
9/30/20170-28N/A-21N/A
6/30/20170-25N/A-16N/A
3/31/20170-14N/A-9N/A
12/31/20160-11N/A-8N/A
12/31/20150-9N/A-5N/A
12/31/20142-6N/A-4N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: SVRA is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: SVRA is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: SVRA is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: SVRA's revenue (71.6% per year) is forecast to grow faster than the US market (9.1% per year).

High Growth Revenue: SVRA's revenue (71.6% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if SVRA's Return on Equity is forecast to be high in 3 years time


Discover growth companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 11:14
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Savara Inc. is covered by 14 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Dewey SteadmanCanaccord Genuity
Joshua SchimmerEvercore ISI
Liisa BaykoEvercore ISI